Assessing the real-world safety of vutrisiran for transthyretin-mediated amyloidosis with polyneuropathy: Based on WHO-VigiAccess and FAERS databases
评估vutrisiran治疗转甲状腺素蛋白介导的伴多发性神经病变的淀粉样变性的真实世界安全性:基于WHO-VigiAccess和FAERS数据库
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0347417
Tong, Weiwei; Li, Yaxing; Xu, Xingli; Mao, Yang; Zhang, Ruonan; Zhao, Chuanliang; Zhang, Jidang; Du, Chigang; Feng, Jiayue